接受大型泌尿妇科手术的老年患者中衰弱与活动能力对结局的影响:ASPIRe三臂随机试验的计划性补充研究
在9个临床中心的146例65岁及以上症状性阴道穹隆脱垂患者中开展前瞻性巢式队列研究,评估衰弱与活动能力对术后并发症、老年结局及治疗失败的影响;衰弱/衰弱前期患者与不衰弱者老年特异性结局无差异,但独自居住者术后6周更需支持,且衰弱或活动能力受损者治疗失败时间更短(校正HR 2.1,95%CI 1.2–3.6)。
要点
- 衰弱/衰弱前期患者与不衰弱者老年特异性结局无差异
- 术前独自居住的衰弱/衰弱前期患者术后6周更需家人朋友或协助支持(19% vs 6%,P=.04)
- 衰弱或活动能力受损者治疗失败时间短于不衰弱或无活动能力受损者(校正HR 2.1,95%CI 1.2–3.6)
核心结论
- 尽管存在可测量的衰弱或活动能力受损,许多老年患者接受脱垂手术时并发症较少;但术后前6周需要增强社会支持。
- 术前衰弱患者治疗失败率更高,提示衰弱对老年盆腔器官脱垂矫正手术规划重要。
研究设计与样本
- 三臂随机临床试验内的巢式前瞻性队列研究,在9个临床中心纳入146例65岁及以上症状性阴道穹隆脱垂患者。
- 衰弱采用Robinson衰弱指数评估,评分0–7分,≥2分视为衰弱前期/衰弱;活动能力受损定义为计时起立行走≥15秒、使用辅助器具或观察到步态困难。
主要发现
- 146例补充研究参与者接受随机脱垂手术:经阴道自体组织修补50例、腹部骶骨阴道固定术47例、经阴道网片修补48例。
- 衰弱/衰弱前期患者与不衰弱者相比,老年特异性结局无差异。
- 术前独自居住的衰弱/衰弱前期患者术后前6周更可能需要支持(家人/朋友或协助)(19% vs 6%,P=.04)。
- 衰弱和活动能力受损患者手术治疗失败时间短于不衰弱或无活动能力受损患者(衰弱 vs 不衰弱校正风险比2.1;95%置信区间1.2,3.6)。
关键数值与推荐
- 主要结局为术后即刻中重度不良事件,按Clavien-Dindo严重程度分类(≥II级)评估。
- 老年特异性结局包括术后30天并发症、术后6周评估的社会支持需求增加、跌倒、新入住专业护理机构、全因住院和死亡。
- 治疗结局为复合治疗失败时间;老年和治疗结局每半年评估一次,持续36至60个月。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The impact of frailty and compromised mobility on immediate postoperative complications, geriatric outcomes, and treatment failure after prolapse surgery remains uncertain. The objective of this study was to prospectively characterize frailty and mobility and their impact on immediate postoperative complications, geriatric outcomes, and treatment success in older patients undergoing major urogynecologic surgery for pelvic organ prolapse. STUDY DESIGN: A nested prospective cohort study within a 3-arm randomized clinical trial was conducted at 9 clinical sites in 146 participants. Participants aged ≥65 years with symptomatic vaginal vault prolapse underwent baseline assessments of frailty and compromised mobility. Frailty was measured using the Robinson Frailty Index. The Robinson Frailty Index score ranges from 0 to 7 and scores ≥2 were considered prefrail/frail. Compromised mobility was defined as Timed Up and Go ≥15 seconds, use of an assistive device, or observed gait difficulties. The primary outcome was immediate postoperative moderate to severe adverse events assessed according to the Clavien-Dindo Severity Classification (grade≥II). Geriatric-specific outcomes included 30-day postoperative complications, need for increased social support assessed 6 weeks postoperatively, falls, new admission to skilled nursing facilities, all-cause hospital admissions, and mortality. Treatment outcome was time to composite treatment failure. Geriatric and treatment outcomes were assessed biannually for 36 up to 60 months. RESULTS: 146 supplemental study participants underwent randomized prolapse surgery in the main trial: 50 in the transvaginal native tissue repair, 47 in the abdominal sacral colpopexy, and 48 in the transvaginal mesh repair arms. Compared with nonfrail subjects, prefrail/frail participants experienced no difference in geriatric-specific outcomes. Prefrail/frail participants living alone before surgery were more likely to require support (family/friends or assistance) in the first 6 weeks after surgery (19% vs 6%, P=.04). Prefrail/frail and compromised mobility participants had a shorter time to surgical treatment failure than did nonfrail or noncompromised patients (frail vs nonfrail adjusted hazard ratio, 2.1; 95% confidence interval, 1.2, 3.6). CONCLUSION: Despite measurable frailty or compromised mobility, many older patients underwent prolapse surgery with few complications; however, enhanced social support was needed in the first 6 weeks after surgery. Treatment failure was higher in patients with preoperative frailty, suggesting that frailty is important to incorporate in surgical treatment planning for the correction of pelvic organ prolapse in older patients.
引用
- Erekson E, Menefee SA, Whitworth R, et al. Outcomes by frailty and mobility in older patients undergoing major urogynecologic surgery: a planned supplementary study of the apical suspension repair for vault prolapse in a three-arm randomized (ASPIRe) trial. Am J Obstet Gynecol. 2025. PMID: 41213491. doi:10.1016/j.ajog.2025.11.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。